Autonomix Medical, Inc. (AMIX)

Autonomix Medical Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	11.82	8.61	0.87	2.04
Cash & Short-Term Investments	11.82	8.61	0.87	2.04
Cash Growth	870.69%	895.14%	-57.68%	-
Other Current Assets	0.11	0.78	-	0.01
Total Current Assets	11.93	9.39	0.87	2.05
Property, Plant & Equipment	0.02	0.02	-	-
Total Assets	11.95	9.41	0.87	2.05
Accounts Payable	0.23	0.49	0.17	0.09
Accrued Expenses	0.88	0.29	0.05	0
Total Current Liabilities	2.25	0.78	0.22	0.09
Long-Term Debt	-	1	-	-
Total Liabilities	2.25	1.78	0.22	0.09
Common Stock	0	0.02	0.01	0.01
Additional Paid-In Capital	56.89	46.58	24.18	23.5
Retained Earnings	-47.19	-38.97	-23.54	-21.55
Shareholders' Equity	9.71	7.63	0.64	1.96
Total Liabilities & Equity	11.95	9.41	0.87	2.05
Total Debt	1.13	1	-	-
Net Cash (Debt)	10.69	7.61	0.87	2.04
Net Cash Growth	-	779.31%	-57.68%	-
Net Cash Per Share	10.09	10.40	1.44	19.73
Filing Date Shares Outstanding	2.46	0.94	0.89	0.1
Total Common Shares Outstanding	2.46	0.94	0.62	0.1
Working Capital	9.69	8.61	0.64	1.96
Book Value Per Share	3.94	8.10	1.04	18.91
Tangible Book Value	9.71	7.63	0.64	1.96
Tangible Book Value Per Share	3.94	8.10	1.04	18.91

Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q